Outcomes of cesarean myomectomy among pregnant women with uterine leiomyomas: A single tertiary center experience

Abstract

Abstract Purpose: This study aimed to investigate the surgical outcomes and safety of cesarean section myomectomies. Methods: This retrospective study was performed between January 2015 and August 2022, at a single university hospital. Pregnant women diagnosed with myoma uteri who underwent C/S (cesarean section) myomectomy and pregnant women without myoma as the control group and only underwent C/S were included in the study. Patients' age, gravida, parity, abortion, body mass index (BMI), delivery week, previous delivery type, myoma size, type, number, localization, preoperative and postoperative hemoglobin (Hb) values and postoperative Hb changes, operation time, hospital stay, blood transfusion need and amount, and postoperative complications were recorded from the hospital archive system. The obtained data were compared between the two groups. Results: A total of 283 patients underwent C/S myomectomy and 324 patients who did not have myoma underwent only C/S. Duration of operation, length of hospital stay, postoperative blood transfusion need and amount of blood transfusion, preoperative Hb, and change of Hb values were statistically significantly higher in the C/S myomectomy group (p<0.01, p<0.01, p=0.005, p= 0.006, p<0.01, p<0.01, respectively). A statistically significant weak positive correlation was observed between fibroid size and hospital stay (ρ=0.133). There was a statistically significant weak positive correlation between the size of myoma and the amount of blood transfused (ρ=0.120). Conclusion: Myomectomy during cesarean section has a low complication rate and saves patients from the necessity of a second operation.